GRDN

$GRDN chatter on StockTwits

• 
  Damian@ZephixBullish4d

  $GRDN High-single-digit organic growth expected with additional M&A upside.

  View on StockTwits ↗
• 
  Stocktwits Relative Strength@STRelativeStrength6d

  $GRDN undiscovered breakout with 84 watchers

  View on StockTwits ↗
• 
  MarketBeat Earnings@EarningsInsiderAug 6

  https://www.marketbeat.com/earnings/reports/2026-8-6-guardian-pharmacy-services-inc-stock/ $GRDN Guardian Pharmacy Services Earnings Trans

  View on StockTwits ↗
• 
  Stocktwits Earnings@StocktwitsEarningsAug 6

  $GRDN Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.35 up 133.33% YoY • Reported revenue of $351.77M up 2.16% YoY

  View on StockTwits ↗
• 
  SuperGreenToday@SuperGreenTodayJun 5

  $GRDN Share Price: $40.52 Contract Selected: Jan 15, 2027 $40 Calls Buy Zone: $4.25 – $5.25 Target Zone: $7.55 – $9.23 Potential Upside: 68% ROI Time to Expiration: 223 Days | Updates via https://fxcapta.com/stockinfo/

  View on StockTwits ↗
• 
  Anthony Larson@Radio06211BullishMay 21

  $GRDN strong a strong company and growth and nobody watching

  View on StockTwits ↗
• 
  MarketBeat.com@MarketBeatMay 10

  https://marketbeat.com/a/8646132/ $GRDN Guardian Pharmacy Services Q1 Earnings Call Highlights

  View on StockTwits ↗
• 
  Stocktwits Earnings@StocktwitsEarningsMay 6

  $GRDN Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.21 up 40.00% YoY • Reported revenue of $336.6M up 2.21% YoY • Guardian Pharmacy Services updated its full-year 2026 Adjusted EBITDA guidance to $123M - $127M, an increase from previous guidance, while maintaining revenue guidance at $1.4B - $1.42B.

  View on StockTwits ↗
• 
  ASE@SilverEagleBullishMar 24

  $GRDN breaking out on the monthly

  View on StockTwits ↗
• 
  Briefing.com@briefingcomMar 19

  $GRDN: Guardian Pharmacy Services (-5.4%) announces pricing of upsized underwritten public offering of class A common stock https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20260319061401GRDN&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

  View on StockTwits ↗
• 
  DonCorleone77@DonCorleone77Mar 19

  $GRDN Guardian Pharmacy prices 6M shares at $31.00 in upsized public offering Guardian Pharmacy Services announced the pricing of its upsized underwritten public offering of 6,000,000 shares of its Class A common stock at a public offering price of $31.00 per share, of which 4,980,000 shares will be sold by certain selling stockholders and 1,020,000 shares will be issued and sold by Guardian as part of a non-dilutive "synthetic secondary" transaction. In addition, the selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 900,000 shares of Class A common stock at the public offering price, less the underwriting discount. The Offering is expected to close on March 20, 2026, subject to customary closing conditions. The Offering is considered non-dilutive as Guardian intends to use all of the net proceeds it receives in the Offering to repurchase from certain stockholders 1,020,000 shares of Class A common stock, at a purchase price per share equal to the public offering price in the Offering, less the underwriting discount. Accordingly, Guardian will not retain any proceeds from the Offering and, upon completion of the Offering and the Synthetic Secondary, the total number of outstanding shares of Class A common stock will remain the same. The shares to be repurchased by Guardian consist of shares of Class A common stock that were issued upon conversion of shares of Guardian's Class B common stock that were originally issued in connection with its corporate reorganization in September 2024. The repurchases are expected to be completed not later than March 24, 2026, subject to closing of the Offering. Guardian will not receive any proceeds from the offering of shares by the selling stockholders in the Offering. BofA Securities, Jefferies and Raymond James are acting as joint bookrunners for the proposed Offering. Stephens Inc. and Oppenheimer & Co. are acting as co-managers for the proposed Offering.

  View on StockTwits ↗
• 
  John Jay@BlueWalkerMar 19

  $GRDN Guardian Pharmacy Services, Inc. (“Guardian”) (NYSE: GRDN) today announced the launch of a proposed underwritten public offering (the “Offering”) of 5,000,000 shares of its Class A common stock, consisting of 3,980,000 shares being offered by certain selling stockholders and 1,020,000 newly issued shares being offered by Guardian as part of a non-dilutive “synthetic secondary” transaction, as described below. In addition, the selling stockholders intend to grant the underwriters a 30-day option to purchase up to an additional 750,000 shares of Class A common stock at the public offering price, less the underwriting discount.

  View on StockTwits ↗
• 
  John Jay@BlueWalkerMar 19

  $GRDN Adding 5 million shares to the float. I wonder how the market will react.

  View on StockTwits ↗
• 
  J@DoozioBullishMar 12

  $UTHR now they are worried about oil while this gorilla is ready to bust outta da $GRDN

  View on StockTwits ↗
• 
  Stocktwits Earnings@StocktwitsEarningsMar 11

  $GRDN Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.33 up 73.68% YoY • Reported revenue of $397.62M up 17.44% YoY

  View on StockTwits ↗

Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.